A Phase III Study of Ivonescimab + Chemo With/Without AK117 in Metastatic Pancreatic Cancer
Akeso
Akeso
Arcus Biosciences, Inc.
Amgen
FutureGen Biopharmaceutical (Beijing) Co., Ltd
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Genfleet Therapeutics (Shanghai) Inc.
Qilu Pharmaceutical Co., Ltd.
Innovent Biologics (Suzhou) Co. Ltd.
ImmunoGenesis
Angiodynamics, Inc.
NantCell, Inc.
Jiangsu HengRui Medicine Co., Ltd.
Sumitomo Pharma America, Inc.
AstraZeneca
Celgene
SynCore Biotechnology Co., Ltd.
Health Clinics Limited
GC Cell Corporation
Gilead Sciences
Bausch Health Americas, Inc.
AB Science
Eli Lilly and Company
Lumos Pharma
Lumos Pharma
Orient Europharma Co., Ltd.
Celgene
Incyte Corporation
AB Science
Incyte Corporation
Astellas Pharma Inc
GlaxoSmithKline
Traws Pharma, Inc.
Par Pharmaceutical, Inc.
Merrimack Pharmaceuticals
Sanofi
Sanofi
Sanofi
Sanofi
Hoffmann-La Roche
Cancer Advances Inc.
Cancer Advances Inc.
INSYS Therapeutics Inc
Eisai Inc.
Taiho Pharmaceutical Co., Ltd.
Wellstat Therapeutics
GenVec
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Pfizer
Threshold Pharmaceuticals